Lan Mi

Lan Mi

Auto-generated profile, based on publicly available information

Lan Mi

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2017 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
YPYuting Peng
Yuting Peng
XZXiongze Zhang
Xiongze Zhang
LMLan Mi
Lan Mi
BLBing Liu
Bing Liu
CZChengguo Zuo
Chengguo Zuo
Feng WenFeng Wen
Feng Wen
To evaluate the efficacy and safety of intravitreal conbercept (KH902) as the primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy. This study was a retrospective, consecutive, observational case series. We reviewed medical records of 16 eyes (16 patients) with naive subfoveal or juxtafoveal choroidal neovascularization secondary to punctuate inner choroidopathy that were treated with intravitreal conbercept injections. All patients completed at least six months of follow-up. Best-corrected visual acuity (BCVA) was measured, and anatomical features were assessed with fluorescein angiography, indocyanine green angiography, and optical coherence tomography. At the month-6 follow-up visit, best-corrected visual acuity improved from 0.70 ± 0.36 (with approximate Snellen equivalent of 20/100) to 0.44 ± 0.25 (20/50 in Snellen) logarithm of the minimum angle of resolution (logMAR) (P = 0.003). Mean improvement of vision was 2.6 lines, with 50% treated eyes (8 eyes of 16) showing an improvement of ≥3 lines and 62.5% (10 eyes of 16), obtaining an improvement of ≥2 lines; all 16 eyes had stable or improved vision. Mean central retinal thickness decreased from 294.94 ± 102.68 μm to 206.56 ± 61.71 μm (P = 0.005). Fifteen eyes (93.75%) showed absence of CNV leakage at the end of the study period. No conbercrept-related systemic or ocular adverse events were observed. Intravitreal injection of conbercept significantly improved visual and anatomical outcomes in choroidal neovascularization secondary to punctate inner choroidopathy over a 6-month follow-up period. ISRCTN85678307 , retrospectively registered on May 11, 2017.

1 February 2018 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
YPYuting Peng
Yuting Peng
XZXiongze Zhang
Xiongze Zhang
MLMiaoling Li
Miaoling Li
BLBing Liu
Bing Liu
LMLan Mi
Lan Mi
Feng WenFeng Wen
Feng Wen
Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy Yuting Peng, Xiongze Zhang, Miaoling Li, Bing Liu, Lan Mi, Chengguo Zuo, Feng Wen State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China Introduction: To evaluate the functional and morphological outcomes of intravitreal conbercept monotherapy in patients with polypoidal choroidal vasculopathy (PCV). Materials and methods: In this retrospective, observational case series study, we reviewed medical records of 48 eyes (48 patients) with naive PCV that were treated with a series of 3 monthly intravitreal injections of 0.5 mg of conbercept followed by as-needed injections (3+pro re nata). All patients completed at least 6 months of monthly follow-up. Changes in the best-corrected visual acuity, optical coherence tomography, and indocyanine green angiography were retrospectively evaluated. Results: At 6 months, the mean best-corrected visual acuity significantly improved from 0.89±0.35 (20/160 in Snellen equivalent) at baseline to 0.58±0.26 (Snellen equivalent of 20/80; P<0.001), and 60.42% (29/48) of eyes had an improvement of three lines of vision; the mean central retinal thickness significantly decreased from 333.56±171.04 µm at baseline to 187.65±54.46 µm (P<0.001), and 93.75% (45/48) achieved a dry macula. At 3 months, 6 of 32 eyes (18.75%) showed partial regression of branching vascular network, 14 of 32 (43.75%) patients showed complete resolution of polyps. The mean number of injections was 3.4±0.9 through 6 months. No conbercept-related systemic or ocular adverse effects were observed. Conclusion: Intravitreal injection of conbercept using “3+pro re nata” regimen significantly improved visual acuity and anatomical outcomes in treatment-naive patients with PCV. Keywords: conbercept, intravitreal injection, PCV, short-term efficacy, “3+PRN”

13 August 2018 in Journal of Ophthalmology
Verified
Journal Article
Open access
LMLan Mi
Lan Mi
CZChengguo Zuo
Chengguo Zuo
XZXiongze Zhang
Xiongze Zhang
BLBing Liu
Bing Liu
YPYuting Peng
Yuting Peng
Feng WenFeng Wen
Feng Wen
Purpose. To determine whether fluorescein leakage within subretinal hemorrhage is definitely suggestive of choroidal neovascularization (CNV) by multimodal imaging including optical coherence tomography angiography (OCTA). Methods. Twenty-five consecutive highly myopic patients (25 eyes) with fluorescein leakage within subretinal hemorrhage detected within 1 month were prospectively included. All patients underwent OCTA and spectral-domain optical coherence tomography (SD-OCT). The OCTA and SD-OCT findings at the site of fluorescein leakage were analyzed. In cases of a doubtful diagnosis, indocyanine green angiography (ICGA) was also performed to differentiate myopic CNV from lacquer crack if necessary; all patients were followed up by SD-OCT and/or OCTA for at least 2 weeks. Results. In terms of the site of fluorescein leakage, OCTA revealed an abnormal vascular network in the outer retina and a choriocapillaris slab in 22 out of 25 eyes (88%), which were confirmed to be CNV. However, no high-flow signal was observed in 3 of 25 eyes (12%). In these 3 cases, SD-OCT showed a focal rupture of the retinal pigment epithelium-Bruch’s membrane-choriocapillaris (RPE-BM-CC) complex and a columnar hyperreflective signal of blood originating from defects with a volcanic geyser-like appearance, and no exudative signs were detected. Notably, all ruptures of the RPE-BM-CC complex were located exactly at lacquer crack sites. Moreover, with the absorption of subretinal hemorrhage, ruptures of the RPE-BM-CC complex spontaneously resolved without any intervention. Considering the multimodal imaging appearance and follow-up outcomes, these 3 eyes were eventually diagnosed as simple bleeding associated with lacquer cracks. Conclusions. Dye leakage within recent subretinal hemorrhage on FA could be caused by new-onset lacquer cracks in pathologic myopia. Multimodal imaging including OCTA is helpful to differentiate lacquer cracks from myopic CNV.

15 November 2024 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Open access
GHGuiqin He
Guiqin He
XZXiongze Zhang
Xiongze Zhang
YJYuying Ji
Yuying Ji
MLMiaoling Li
Miaoling Li
XHXinlei Hao
Xinlei Hao
Feng WenFeng Wen
Feng Wen
Purpose: This study aimed to elucidate the distribution and morphological features of choroidal vortex veins in pachychoroid disease (PCD). Design: Retrospective observational study. Subjects: Patients with PCD included from January 2022 to June 2023. Methods: We conducted a retrospective cross-sectional analysis using wide-field indocyanine green angiography (WF-ICGA) to assess choroidal vortex veins in PCD patients, categorizing them based on location (equatorial/ posterior) and morphology (absent, incomplete, complete, complete with ampulla). Main Outcome Measures: The incidence of different location and morphology of vortex veins in PCD. Results: A total of 190 eyes from 99 PCD patients were examined. Notably, only 8.9 % (17/190) of eyes had posterior vortex veins. We identified 1620 vortex veins, predominantly equatorial (99 %, 1603/1620). Morphologically, the most common type was incomplete (61.9 %), followed by complete (19.5 %), absent (11.1 %), and complete with ampulla (7.5 %). The distribution of these veins varied, with the inferotemporal quadrant showing the highest prevalence at 26.9 %, followed by the superonasal (26.1 %), superotemporal (24.3 %), and inferonasal (22.7 %) quadrants. The median number of vortex veins per eye was 8, with a range from 5 to 15. Conclusions: This study highlights that posterior vortex veins are less frequent in PCD eyes, with incomplete veins being the most prevalent. These findings provide important clinical evidence for understanding the distribution and morphologic characteristics of choroidal vortex veins in PCD, contributing to our knowledge of the pathophysiological mechanisms underlying this condition.

21 June 2026 in Communications Medicine
Verified
Journal Article
Open access
PDF file
JPJiaxin Pu
Jiaxin Pu
YJYuying Ji
Yuying Ji
MLMiaoling Li
Miaoling Li
XZXiongze Zhang
Xiongze Zhang
CZChengguo Zuo
Chengguo Zuo
Feng WenFeng Wen
Feng Wen
Background Hard drusen appear as hyperfluorescent dots on indocyanine green angiography (ICGA) due to their high phospholipid content. This study aims to explore the distribution of peripheral hard drusen across age groups and retinal regions, and their correlation with macular pathology including hard drusen, soft drusen, and progression to neovascular age-related macular degeneration (nAMD). Methods A hospital-based retrospective study was conducted at Zhongshan Ophthalmic Center. Patients who underwent ICGA over a five-year period were included and categorised into seven age groups. Hard drusen were quantified across nine retinal quadrants using the Trainable Weka Segmentation machine learning plugin. A subgroup of patients underwent imaging follow-up to assess progression to nAMD. Results Here we show, across 1562 normal eyes (14,058 ICGA images) quantified using a validated machine learning model (Dice coefficient: 0.697; sensitivity: 82.93%; ICC: 0.944), that age 50 represents a critical threshold for drusen accumulation, with significant increases observed across all nine quadrants. The nasal quadrants demonstrate earlier and more prominent drusen accumulation compared to the temporal quadrants (P < 0.001 across ages 20–69 years). Notably, the central superior quadrant shows consistent associations with macular hard drusen counts (Stdβ = 0.104, P = 0.010), soft drusen volume (ρ = 0.657, P = 0.020), and progression to nAMD (OR = 1.324, P = 0.040). Conclusions Peripheral hard drusen accumulate preferentially in the nasal quadrants and increase markedly after age 50. Comprehensive peripheral retinal evaluation during ICGA examination may hold potential clinical value for AMD monitoring, pending further prospective validation.